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1. Introduction 
The microorganisms living on and inside the human body are called the ‘human 
microbiome’.  This large and varied collection of organisms has been studied mainly 
using culturing techniques and focusing on disease-causing organisms.  With the 
development of genome sequencing technology it has become possible to study entire 
microbial communities.  A popular method known as ‘16S sequencing’ focuses on 
sequencing just one gene, the 16S ribosomal RNA gene, across all organisms in a 
sample.  This allows identification of the taxonomic structure of a community.  
Comprehensive genetic sequencing of all microbial DNA in a sample, called 
‘metagonomic shotgun sequencing’, can identify the functional potential of a microbial 
community.  
The human microbiome has been compared to an organ (Baquero and Nombela, 2012; 
Evans et al. 2013).  Until recently it has been a ‘forgotten’ or ‘neglected’ organ, but 16S 
and metagenomic shotgun sequencing have brought a new appreciation for the 
significance of the human microbiome to understanding human biology and treating 
human disease. 
The microbiota of the human body consist of thousands of taxonomically distinct 
organisms including members of the Archea, Prokaryota, and single-celled Eukaryota 
plus their attendant viruses.  Variation of microbiome between individuals is very high but 
there are discernable similarities between family members (Spor et al., 2011).  
Conservative estimates put the number of microbial cells living on and inside a human 
host at three times the number of the host’s cells and having a combined weight of 
several pounds.  While microbial genomes are relatively small compared with the human 
genome, collectively the human microbiome is believed to harbor more genes than its 
host (Turnbaugh et al., 2007). 
These microbes and their genes provide a wide range of beneficial functions not 
otherwise available from the human genome.  There are many studies in animal models 
that have found complex interactions between the microbiome and the host related to 
development and homeostasis of the immune system.  Studies in Drosophila and 
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zebrafish have found that the immune system operates not only to attack pathogens but 
also to develop and maintain the population of commensal gut microorganisms by 
inhibiting inflammatory responses to desirable species.  Studies in mice have described 
similar mechanisms and in addition found evidence that the host immune system 
influences the spatial distribution of gut microbiota.  In humans it has been shown that a 
particular commensal bacteria, Bacteroides fragilis, plays a role in immune system 
development as a promoter of CD4+ T cells (Chu and Mazmanian, 2013). 
In addition to its complex interactions with the immune system, the human gut 
microbiome provides metabolic functions not present in the human genome.  These 
include genes enabling fermentation of complex carbohydrates to produce short-chain 
fatty acids that can be absorbed by the host, and for synthesizing and metabolizing 
vitamins (Yatsunenko et al., 2012).  In addition, the by-products of microbial metabolism 
in the gut signal the host intestine, liver, muscle and adipose tissues (Tremaroli and 
Backhed, 2012), and perhaps the brain as well (Collins et al., 2012). 
Increased understanding of the widespread commensal relationships between human 
hosts and their microbiome has made it clear that the genetic basis of human health and 
disease is not strictly encapsulated by the human genome.  In this sense the microbiome 
is a new frontier for understanding and treating disease.  Several studies have identified 
potential biomarkers between colorectal cancer and microbiome.  In one study stool 
samples from subjects with colorectal cancer were found to have increased abundance 
of Fusobacterium and Porphyromonas and reduced numbers of species considered 
beneficial as compared with healthy subjects (Zackular et al., 2014).  A study of 
microbiome from biopsied tissue found increased microbial diversity and increased 
abundance of predicted virulence genes at the tumor site as compared with subject-
matched normal tissue (Burns et al., 2015).  Significant disturbance of the host 
microbiome, or dysbiosis, is associated with several disease states including 
inflammatory bowel disease (Baumgart and Carding, 2007), C. dificile infection 
(Kachrimanidou and Malisiovas, 2011), and obesity (Ley, 2010).  In some cases directly 
treating the microbiome has led to improved outcomes (Khoruts et al., 2010). 
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The evidence pointing to significant relationships between human health and disease 
with the state of the human microbiome is compelling, and naturally leads to questions of 
how the human genome and human microbiome interact.  This question has been 
mainly addressed in mouse studies and human twins studies. 
A 2011 review by Spor et al. reports on several studies of human monozygotic (MZ) and 
dizygotic (DZ) twins with conflicting results.  A nucleic acid fingerprinting-based study of 
not more than 20 pairs of MZ and DZ twins reported an effect of host genetics on gut 
microbiome (Stewart et al., 2005).  A later study using 16S and shotgun metagenomic 
sequences failed to find any heritable taxa in stool samples from 31 MZ and 23 DZ twin 
pairs (Turnbaugh et al., 2009).  Both studies were probably hampered by small sample 
sizes. 
A quantitative trait loci (QTL) study (Benson et al., 2010) of 645 mice defined a ‘core 
measureable microbiota’ of 64 microbial taxa found in all or nearly all mice.  Maternal 
and litter effects were found to account for 26% of the variation in these 64 taxa.  The 
core measurable microbiota were analyzed for quantitative trait association with 530 
SNP markers.  Of the 64 core measureable taxa, 26 were significantly related to 13 
genomic regions and 6 suggestive quantitative trait loci. 
A recent human twins study (Goodrich et al., 2014]) analyzed stool samples from 416 
twin pairs from the TwinsUK cohort.  This study found that the microbiomes of MZ twins 
were more highly correlated than those of DZ twins, and identified a network of heritable 
microorganisms.  One particular family, Christensenellaceae, was found to be the most 
heritable taxon.  Furthermore, the interaction of host genetics with microbiome was 
tested directly with a member of the Christensenellaceae family in a mouse model.  
Germ-free mice were inoculated with a human gut microbiome associated with obesity to 
which had been added a cultured species, Christensenella minuta.  This modified 
microbiome reduced weight gain in recipient mice relative to mice that received the same 
human gut microbiome without added C. minuta.  In addition, over time the two 
treatments resulted in significant differences in gut microbiome.  The authors interpret 
this result as showing interaction between microbiome and host genotype. 
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With recognition that the human microbiome is an additional component of genetic 
variation that interacts in complex ways with its host, it becomes clear that 
understanding individual susceptibility to disease and response to treatment will require 
more than just decoding the human genome in isolation.  The recent study by Goodrich 
et al., 2014 finds strong evidence of host genetic variation interacting with the human 
microbiome to influence obesity, and many more discoveries of disease-related 
interactions are anticipated.  Mapping the full range of host-microbiome interactions will 
require studies of large cohorts from diverse populations and will ultimately address 
questions of basic human evolution and biology in addition to informing clinical practices. 
We are interested in finding these interactions between the human microbiome and host 
genetic variations. We have developed a method using LASSO regression to screen for 
microbial taxon abundances, or other related measurements, with a linear relationship to 
SNPs in the host genome.  Linear relationships are of particular interest because they 
are likely to represent large effects resulting from interactions among a group of genes.  
We have applied our method to data from 16S and metagenomic shotgun sequencing 
published by the Human Microbiome Project. 
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2. Methods 
Our goal is to find linear associations between microbial abundance and single 
nucleotide polymorphisms in the host genomes of 93 human subjects.  The microbial 
abundance data derived from 16S sequencing is reported for 15 different body sites per 
subject.  For each body site we work with a taxon abundance table of 100 to 400 relative 
microbial abundances per human subject.  In addition KEGG module abundance data 
derived from metagenomic shotgun sequencing is reported for 250 modules at 5 body 
sites per subject.  Our host genetic variation data is a set of 32,698 SNPs in exons, 
although we do not have data on every SNP for every subject.  We encode subject 
genotype for a given SNP as the count of alternative nucleotides: 0, 1, or 2. 
Our data falls in the category ‘𝑝 ≫ 𝑛’, which means the number of predictors exceeds the 
number of samples by a large margin.  In our case we typically have more taxon 
abundances, or KEGG module abundances, than human subjects by a factor of 2 or 
more.  Additionally, in cases of association between a SNP and microbial abundances 
we expect a ‘sparse’ model, meaning only a small number of the taxon abundances are 
involved.  We use LASSO regression (Least Absolute Shrinkage and Selection 
Operator), which is designed to find sparse linear models and in addition is 
computationally efficient (Tibshirani, 1996; Efron et al., 2004). 
The first step in screening for association between a SNP and microbial abundance data 
is to fit a model using LASSO regression for each SNP and for abundance data at each 
body site.  Next we estimate the false positive rate of the LASSO regression on each 
data set to determine if we have found meaningful results.  We then use randomized 
LASSO to choose relevant taxa, and finally pathway and network analysis to place 
selected genes in context.  Figure 2.1 shows the analysis pipeline. 
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Figure 2.1 Analysis pipeline 
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LASSO 
LASSO regression fits the usual linear model composed of 𝑛 observations of 𝑝 features 𝑋!,!   (1 ≤ 𝑖 ≤ 𝑛, 1 ≤ 𝑗 ≤ 𝑝) and 𝑛 responses 𝑦!   (1 ≤ 𝑖 ≤ 𝑛): 𝑋𝛽 = 𝑦 
in a way that minimizes the loss function 
𝐿 = 𝑦! − 𝑦! !!!!! + 𝛼 𝛽!
!
!!! 	  
In our model of association between a SNP and microbial abundances the matrix 𝑋 
corresponds to a table of abundances (at a particular body site) and the vector 𝑦 
corresponds to the alternate allele count (0, 1, or 2) for each subject for the given SNP.  
More specifically, each element 𝑋!,! is the abundance value of taxon 𝑗 measured for 
human subject 𝑖.  Each element 𝑦! is the observed alternate allele count for human 
subject 𝑖, and each element 𝑦! is the predicted alternate allele count for the same 
subject.  Each element 𝛽! is the jth regression coefficient (1 ≤ 𝑗 ≤ 𝑝 where 𝑝 is the 
number of abundances at the body site), and 𝛼 is a scalar tuning parameter. 
The 𝛼 parameter is typically determined by cross-validation for each dataset as part of 
the model fitting process.  The LASSO loss function is convex and so it is solvable by 
general-purpose convex optimization algorithms.  However, there are special-purpose 
algorithms for LASSO optimization that are simpler and more efficient, such as least-
angle regression (LARS) (Efron et al., 2004). 
LASSO regression is similar to usual multivariate linear regression.  If the tuning 
parameter 𝛼 is set to 0 then the LASSO solution will be identical to the multivariate linear 
regression solution.  As 𝛼 increases fewer features are retained in the LASSO solution, 
until at some high value no features are retained.  The usual method of choosing 𝛼 is to 
pick the value that minimizes the MSE of the solution.  Figure 2.2 shows an example of 
the effect of increasing 𝛼 on the LASSO solution. 
	  	  
8	  
	  
Figure 2.2 LASSO path for a 10-variable example dataset as calculated by the LARS 
algorithm.  Each line corresponds to the regression coefficient of a feature.  The LASSO 
parameter is shown on the horizontal axis increasing from left to right with scaling to 
separate small values that would otherwise be very close together.  For the low values of 𝜶 all features have been selected, as indicated by all coefficients having non-zero 
values.  As 𝜶 increases some coefficients are reduced to zero, removing them from the 
LASSO solution.  At the maximum 𝜶 all feature coefficients have been reduced to zero. 
We developed a program using the Python machine-learning library scikit-learn 
(Pedregosa et al., 2011) to execute LASSO regression with microbiome data as 
predictors and SNP minor allele count as responses.  We use the 𝑅!  statistic from the 
LASSO model as the indicator of correlation between microbiome predictors and host 
genetic responses.  Our program uses the scikit-learn LARS implementation with default 
parameters and 5-fold cross-validation to tune the LASSO parameter 𝛼. 
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We observed high variance in 𝑅! when running LASSO directly on our data.  We found 
the usual 5-fold and 10-fold cross-validation did not reduce the variance sufficiently to 
give reproducible results.  We managed this variance by randomly shuffling the data and 
repeating the LASSO fitting (with internal 5-fold cross-validation) 100 times splitting 80% 
of the data for training and 20% for testing.  Splits for both the internal 5-fold cross-
validation and the external 100-times resampling were constructed to maintain 
approximately the same genotype distribution as the overall data set.  We assigned the 
median of the 100 𝑅! values to be the nominal 𝑅! for the regression and calculated a 
95% percentile bootstrap confidence interval of the median using 10,000 bootstrap 
samples.  We have realized benefits from this approach including reduced effort in 
significance testing as compared with permutation tests and assessment of data quality. 
Estimating False Positive Rate 
We estimate the false positive rate of our method as a function of 𝑅! on each data set by 
shuffling the allele counts for each SNP among the subjects and repeating the LASSO 
regression procedure.  We can then determine if we have found an enrichment of SNPs 
with high 𝑅! relative to this false positive rate.  We retain the enriched proportion of 
those SNPs having a high ratio 𝑟 of 𝑅! to width of the 95% confidence interval: 
𝑟 = 𝑅!ℎ!" − 𝑙!" 
Here ℎ!" is the upper bound and 𝑙!" is the lower bound of the 95% confidence interval.  
This incorporates an estimate of uncertainty in the data into choosing SNPs to analyze 
further. 
Selecting Relevant Taxa 
We analyze the retained SNPs to determine the taxa most contributing to correlation with 
host genetic variation.  LASSO regression is known to be sensitive to small variations of 
the predictors and for this reason it is common to use a resampling method to choose 
relevant predictors.  We have chosen to use stability selection with randomized LASSO 
(Meinshausen and Bühlmann, 2010).  Stability selection is not a LASSO-specific method 
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but works with any regularized model-fitting algorithm.  The stability selection algorithm 
for a general model is as follows: 
1. Choose a set of model tuning parameter values 𝐴 = {𝛼!,𝛼!,⋯ ,𝛼!}. 
2. For each 𝛼! ∈ 𝐴, repeat N times: 
a. Randomly choose a subset of the data. 
b. Fit the model to the data subset using 𝛼!. 
c. Record the selected predictors. 
3. Calculate the frequency 𝑓! with which each predictor was selected over all trials. 
4. Choose a threshold 𝐹  (0 < 𝐹 < 1) and select the predictors with 𝑓! > 𝐹. 
Randomized LASSO is a slight variation of the usual LASSO that incorporates random 
scaling factors in the penalty term: 
𝐿 = 𝑦! − 𝑦! !! + 𝛼 𝛽!𝑊!! 	  
The 𝑊! are drawn randomly from the interval [𝛾, 1] for a fixed ‘weakness’ 𝛾 ∈ (0,1].  This 
variation of the LASSO model is only useful in a setting such as stability selection where 
the model is repeatedly fit and the results are combined.  One advantage of stability 
selection is that it is less sensitive to the choice of the LASSO parameter than other 
variable selection methods.  Incorporating random scaling in the penalty term improves 
the consistency of the results. 
 We use the implementation of stability selection with randomized LASSO from the scikit-
learn library, and choose N=1000 trials.  We randomly select 80% of the data for each 
trial keeping the distribution of genotypes the same as in the entire data set.  It is 
necessary to provide a range of values of the LASSO tuning parameter so we repeat the 
process of model fitting with LARS and 100-times random shuffling to get a series of 
tuning parameters.  We keep the largest 𝛼  and construct a list of ten evenly spaced 
values ranging from 0.3𝛼 to 𝛼.  This list contains relatively large tuning parameters to 
favor including fewer predictors in each model.  Figure 2.3 shows stability paths for a 
simple example dataset. 
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We do not aggressively tune the threshold 𝐹.  In the case of synthetic data we will look 
at a few values, but for real data we will simply choose 𝐹 such that the number of 
features selected stays small for most SNPs. 
Figure 2.3: Stability paths for an example dataset with 500 features, three of which are 
correlated to the response.  Each line represents the probability that a feature is selected 
as relevant by the stability selection procedure as a function of the LASSO tuning 
parameter 𝛼.  The three paths at the top of the figure are relevant features, the 
remaining paths are irrelevant features.  As the LASSO tuning parameter 𝛼 decreases 
from right to left, the LASSO procedure behaves more like regular regression and more 
variables are selected.  The three relevant features are clearly selected most often out of 
all features. 
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3. Synthetic Data Results 
Synthetic Data 
We generated three synthetic datasets to assess the performance of LASSO regression 
for discovering correlation between SNP minor allele count and microbial abundances.  
Each synthetic dataset was constructed by varying a different parameter to create 
several subsets. In synthetic dataset 1 we varied minor allele frequency.  In synthetic 
dataset 2 we varied the correlated taxon count.  In synthetic dataset 3 we varied total 
taxon count.  Additionally, all three datasets were constructed with varying degrees of 
SNP noise, which was generated by randomly shuffling the minor allele counts of a small 
number of samples. 
Each synthetic data subset contained 100 samples (corresponding to human subjects).  
For each sample we generated a table of synthetic taxon abundances and 500 SNPs 
with a fixed minor allele frequency and correlated with taxon abundances.  Additionally, 
in synthetic datasets 1 and 3 we generated and tested subsets of 10,000 SNPs with no 
correlation to the taxon abundances.  Synthetic dataset 2 included no uncorrelated SNPs 
because the parameter under variation was the number of correlated taxa per SNP.  We 
generated 200 taxon abundances for each sample in datasets 1 and 2.  In dataset 3 we 
used three different total taxon abundance counts: 100, 300, and 500. 
Taxon Abundance 
Each synthetic taxon abundance was determined by exponential transform of a random 
value drawn from a normal distribution with mean 0.0 and standard deviation 1.0.  The 
randomly determined abundances were then normalized to give relative abundances. 
SNP Correlation 
We constructed SNP alleles with correlation to 𝑛 synthetic abundances by applying a 
SNP-specific linear function 𝑓!:ℝ! → ℝ with randomly selected coefficients 𝑐 = (𝑐!, 𝑐!,⋯ , 𝑐!) to a set of randomly selected abundances 𝑎 = (𝑎!, 𝑎!,⋯ , 𝑎!): 𝑓! 𝑐, 𝑎 = 𝑐 ∙ 𝑎 = 𝑐!𝑎! + 𝑐!𝑎! +⋯+ 𝑐!𝑎! 
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The coefficients 𝑐! were drawn from a normal distribution with mean 0.0 and standard 
deviation 1.0.  The distribution of 𝑓! over the selected taxon abundances was partitioned 
into three intervals proportional to SNP allele frequencies as determined by the 
established minor allele frequency.  We assigned the SNP allele for each sample by 
determining to which partition the sample’s 𝑓! value belonged.  SNP alleles were coded 
0, 1, or 2 to indicate the number of alternative nucleotides per SNP. 
We evaluated the degree of correlation between each SNP and the associated 
abundances by linear regression to guarantee a minimum degree of correlation.  We 
retained the synthetic SNP alleles if 𝑅! > 0.35.  Otherwise we repeated the procedure 
with a new 𝑓! until the threshold was met. 
SNP Noise 
We added random, smooth noise at levels 𝑃 = 0.00, 0.05, 0.10 to the correlated SNPs 
while maintaining the chosen minor allele frequency.  To add noise to the distribution of 
allele counts for a correlated SNP, we first randomly selected !"!  samples.  The SNP 
value (alternative allele count 0, 1, or 2) of each selected sample was swapped with that 
of another randomly selected sample.  The noise was ‘smooth’ in the sense that 
swapped samples were constrained to differ in allele count by 1.  This smoothness 
emulates adding noise to the taxon abundances, which results in swapping allele count 0 
with allele count 2 only at very high noise levels.  The advantage of swapping a fixed 
number of allele counts over adding noise directly to the taxon abundances is that we 
can directly control the number of swaps so all SNPs have a consistent level of noise. 
This procedure results in 𝑃𝑁 miscorrelated SNPs while maintaining the original 
distribution of SNP values.  To generate SNP noise at level 𝑃 = 0.05 we generated noise 
for half the SNPs at 𝑃 = 0.04 and for the other half at 𝑃 = 0.06. 
Synthetic Dataset 1 
We constructed this dataset to investigate the effect on LASSO regression of variation in 
minor allele frequency and SNP noise.  This dataset consisted of 12 subsets of 500 
correlated SNPs formed by all pairings of minor allele frequencies 0.25, 0.30, 0.35, and 
0.40 with SNP noise levels of 0.00, 0.05, and 0.10.  In all correlated subsets three taxon 
	  	  
14	  
abundances were randomly selected to generate correlated SNP alleles.  Four subsets 
of 10,000 uncorrelated SNPs were also generated, one for each minor allele frequency. 
In Figure 3.1 sensitivity (ratio of true positives to the sum of true positive and false 
negatives) is shown as a function of SNP noise and minor allele frequency for our 
LASSO procedure on synthetic dataset 1.  There is small fluctuation in sensitivity but no 
dependence on minor allele frequency or SNP noise level. 
	  
Figure 3.1: Sensitivity as a function of minor allele frequency in synthetic dataset 1. 
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Figure 3.2: Specificity as a function of minor allele frequency in synthetic dataset 1. 
Figure 3.2 shows the specificity (ratio of true negatives to the sum of true negatives and 
false positives) as a function of minor allele frequency for our LASSO procedure on 
10,000 uncorrelated SNPs.  It can be seen that specificity of the method is high and has 
no strong dependence on minor allele frequency.  The small number of SNPs mis-
identified as correlated to some taxa may be correlated by chance since the data set is 
large. 
Minor allele frequency and SNP noise have a greater effect on feature selection.  Figure 
3.3 shows the performance of correlated taxon identification by stability selection for 
each level of SNP noise and each minor allele frequency.  Overall feature selection 
performs well on this data.  At all three levels of SNP noise and all four minor allele 
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frequencies, 2/3 or better of correlated taxa are correctly selected on average (mean 
precision > 0.667) and of the selected taxa 2/3 or better are correlated (recall > 0.667). 
	  
Figure 3.3: Mean precision and recall per SNP of feature selection with 95% confidence 
intervals in synthetic dataset 1. 
Synthetic Dataset 2 
We constructed this dataset to observe the effects of varying correlated taxon count and 
SNP noise on LASSO regression results.  This dataset consisted of 9 subsets of 500 
correlated SNPs constructed with all pairings of correlated taxon counts 5, 10, and 20 
with SNP noise levels of 0.00, 0.05, and 0.10.  The SNP minor allele frequency in all 
subsets was fixed at 0.30 and total taxon count was 200. 
Synthetic dataset 2 does not include uncorrelated SNPs since the same parameters are 
represented by the uncorrelated SNPs in dataset 1 with minor allele frequency 0.3. 
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Figure 3.4 shows sensitivity as a function of SNP noise and correlated taxon count for 
our LASSO procedure on synthetic dataset 2.  Increasing SNP noise and increasing 
correlated taxon count cause decrease in sensitivity.  This is most likely due to 
compounding noise with increasing number of noisy SNPs.  This suggests our method 
will be sensitive to noise especially when SNPs are correlated with higher numbers of 
taxa.  With higher numbers of correlated taxa the overall strength of correlation falls 
because our synthetic taxa are random and so will not tend to reinforce each other. 
	  
Figure 3.4: Sensitivity as a function of correlated taxon count per SNP in synthetic 
dataset 2. 
Feature selection precision and recall are also strongly influenced by the correlated 
taxon count per SNP (Figure 3.5).  Precision falls to about 1 2 at 10 correlated taxa and 
about 1 3 at 20 correlated taxa.  SNP noise has a consistent but small effect on 
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precision.  Recall also falls with increasing numbers of correlated taxa, but stays above 
0.5 even at high SNP noise. 
Synthetic dataset 2 is very challenging for our method.  One reason may be that the 
random abundances tend to cancel each other’s effects and so as more abundances are 
combined to correlate with a SNP the more difficult it becomes to select the relevant 
taxa.  This behavior may not be representative of actual correlations between 
microbiome data and host genetic variation. 
	  
Figure 3.5:  Mean feature selection precision and recall per SNP with 95% confidence 
intervals for synthetic dataset 2. 
Synthetic Dataset 3 
We constructed this dataset to investigate LASSO regression with varying total taxon 
count and SNP noise.  This dataset consisted of 9 subsets of 500 correlated SNPs 
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generated from all pairings of total taxon counts 100, 300, and 500 and SNP noise levels 
of 0.00, 0.05, and 0.10.  Three subsets of 10,000 uncorrelated SNPs were generated, 
one for each total taxon count.  The SNP minor allele frequency in all subsets was fixed 
at 0.30. 
Figure 3.6 and Figure 3.7 show sensitivity and specificity as functions of total taxon 
count.  There is some fluctuation in sensitivity but no clear dependence on total taxon 
count or SNP noise.  Specificity is consistent across the different taxon counts.   
This means our method is good at identifying SNPs correlated with taxon abundances 
even at larger taxon counts and in the presence of noise. 
Figure 3.8 shows mean precision and mean recall per SNP for feature precision on 
synthetic dataset 3.  The precision of feature selection is largely unaffected by the total 
taxon count and SNP noise has a consistent but small effect.  Feature selection recall is 
sensitive to increasing taxon table size and to increasing SNP noise. 
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Figure 3.6: Sensitivity as a function of total taxon count in synthetic dataset 3.   
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Figure 3.7: Specificity as a function of total taxon count in synthetic dataset 3.   
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Figure 3.8: Mean feature selection precision and recall per SNP with 95% confidence 
intervals for synthetic dataset 3. 
Discussion 
The synthetic datasets are challenging for several reasons.  The synthetic abundances 
span a wide range of values.  The relationship between abundances and alternate allele 
counts created by the 𝑓! functions is indirect and the coefficients of the 𝑓! are allowed to 
be positive or negative and a few will have very small magnitude because they are 
drawn from a normal distribution.  Nevertheless, our procedure performs well at 
identifying correlated SNPs even under moderate SNP noise.  Identifying the correlated 
taxa is a more difficult problem but this method is almost always able to identify correctly 
a third or more of the correlated taxa in the synthetic datasets. 
We will use the results of the synthetic data studies to inform our work on real data from 
the Human Microbiome Project.  For example, we will preprocess our real data to reduce 
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the number of taxa as much as possible.  We will also filter out SNPs with low minor 
allele frequency. 
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4. HMP 16S Results 
The Human Microbiome Project (Human Microbiome Project Consortium, 2012) has 
collected and published microbiome data from several hundred healthy individuals 
derived from 16S sequencing for 15 body sites and from shotgun metagenomic 
sequencing for 5 body sites.  In addition, the genomes of 93 of these subjects have been 
sequenced with 10x coverage from human genetic material present in the same 
published samples providing data on 3 million SNPs.  We used LASSO regression to 
search for correlations between 32,698 SNPs in exons from these host genomes and 
microbial abundances. 
We acquired OTU tables based on 16S sequencing from the Human Microbiome Project 
that identified microbial taxa at the genus level.  We processed these tables with the 
QIIME (Caporaso, 2010) script ‘summarize_taxa.py’ to produce taxon tables of relative 
abundance for all taxonomic levels from genus to phylum.  We also removed taxa with 
very low abundance (< 0.00005%).  The remaining taxon abundances were clustered at 
using K-medoids clustering with a clustering threshold of 0.95 correlation.  We retained 
the medoid taxon of each cluster for the final taxon table.  Taxon abundances were 
transformed with the square root function followed by the inverse sin function.  Figure S1 
shows the final taxon count for each body site. 
Starting with 32,698 exonic SNPs, we filtered the data to remove SNPs with five or fewer 
homozygous samples, fewer than 50 samples overall, and minor allele frequency less 
than 0.2.  At each body site approximately 14,000 SNPs met the criteria for testing.  
There is some variation across body sites in the number of tested SNPs because a small 
number of subjects do not have abundance data at all 15 body sites.  Figure S2 shows 
the number of SNPs that met the criteria for testing by body site. 
In addition we controlled for subject sex by including it as one of the predictor variables.  
Adding sex to the model rather than regressing it out of the predictors allows the LASSO 
regression process to determine if sex is a relevant variable on a SNP-by-SNP basis. 
The first step is to test for correlation using LASSO regression.  This step produces a 
median 𝑅! and 95% bootstrap confidence interval for each SNP, body site pair.  Of the 
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tested SNPs, we found 250-500 SNPs per body site having 95% confidence interval of 
the median 𝑅! not overlapping 0.  We retained these SNPs for further analysis.  Figure 
S3 shows counts of retained SNPs by body site. 
The second step is to estimate the false positive rate for the SNP and abundance data.  
If we find more SNPs correlated with taxon abundances than the false positive rate 
predicts then we can be confident we have found some meaningful correlations. 
We estimate the false positive rate for each body site by twice repeating the LASSO 
regression procedure on each SNP with the genotypes randomly permuted within the 
male and female groups.  Permuting genotypes across the sexes would result in an 
underestimate of the false positive rate because sex is a significant predictor for a 
number of SNPs and we consider those to be false positive identifications.  SNPs with a 
high correlation to sex (stability score > 0.8) were removed from the final list of SNPs 
correlated with taxon abundances. 
We selected 𝑅! = 0.1 as a reasonable cutoff for considering a SNP to be well-correlated 
with the HMP 16S microbiome data.  We then compared the number of well-correlated 
SNPs in the real data with the number of well-correlated SNPs in the permuted data.   
Figure 4.1 shows, for the stool body site, the superimposed distributions of median 𝑅! 
values for the real data and the average of the two distributions of permuted data.  It is 
clear that this body site has an enrichment of real correlated SNPs relative to the 
permuted correlated SNPs.  Supplemental figures S4-S17 show the superimposed 
distributions for the remaining HMP 16S body sites. 
The body sites most enriched for real well-correlated SNPs are attached keratinized 
ginigiva, buccal mucosa, right antecubital fossa, saliva, stool, subgingival plaque, and 
throat.  The hard palate, palatine tonsils, and tongue dorsum are only slightly enriched.  
The anterior nares, left antecubital fossa, left retroauricular crease, right retroauricular 
crease, supragingival plaque, and supragingival plaque are not enriched for well-
correlated SNPs. 
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Figure 4.1: Superimposed distributions of 𝑅! for actual and permuted data from the stool 
body site.  The figure on the left shows the distribution of SNPs with 𝑅! > 0.  The figure 
on the right shows the distribution of SNPs with 𝑅! > 0.1. It is clear in both figures that 
this body site is enriched for actual correlated SNPs. 
Finally, individual well-correlated SNPs were identified as having significant correlation to 
the HMP 16S microbiome data using the ratio 𝑟 of median 𝑅! to the width of the 
corresponding 95% confidence interval.  If a body site had 𝑁 well-correlated SNPs over 
the number predicted by the false positive rate then the top 𝑁 SNPs ordered by 𝑟 were 
identified as well-correlated.  Identified, well-correlated SNPs and corresponding genes 
are listed in file ‘hmp_16S_snps_genes.xlsx’.  SNPs with high correlation (stability score 
> 0.8) to subject sex were removed.  The SNPs found to have a high correlation to 
subject sex were in genes ALMS1, FAM20A, GLYR1, LIPC, and PRAME.  In all, 14 
SNPs were removed due to high correlation to subject sex leaving 76 SNPs in 72 genes.  
Figure 4.2 shows the final count of identified SNPs. 
Microbial taxa associated with well-correlated genes were identified by randomized 
LASSO with stability score threshold 0.5.  This threshold is a conservative choice that 
identifies at least one microbial taxon per well-correlated SNP. 
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Figure 4.2: Count of SNPs per body site identified as well-correlated with HMP 16S 
microbial abundance. 
Pathway and Network Analysis 
We used QUIGEN’s Ingenuity Pathway Analysis (IPA, QUIGEN Redwood City, 
www.quiagen.com/ingenuity) to perform pathway and network analysis on the list of 
genes containing identified, well-correlated SNPs (the complete list of SNPs and genes 
is found in supplementary file hmp_16S_snps_genes.xlsx).  Figure S18 shows the 
results of the pathway analysis. 
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The list was found to be significantly enriched for five pathways: 
1. Phospholipases 
a. PLA2G12A from the throat body site 
b. PLD2 from the saliva body site 
2. Tryptophan Degradation to 2-amino-3-carboxymuconate Semialdehyde 
a. IDO2 from the buccal mucosa body site 
3. Actin Cytoskeleton Signaling 
a. Gene APC from the subgingival plaque body site 
b. Gene MYH7B from the throat body site 
c. Gene PAK7 from the right antecubital fossa body site 
4. NAD biosynthesis II (from tryptophan) 
a. Gene IDO2 from the buccal mucosa body site 
5. Chondroitin Sulfate Degradation (Metazoa) 
a. Gene ARSB from the buccal mucosa body site 
6. Choline Biosynthesis III 
a. Gene ARSB from the buccal mucosa body site 
7. Antioxidant action of vitamin C 
a. Gene PLA2G12A from the throat body site 
b. Gene PLD2 from the saliva body site 
However, each pathway included only one gene per body site from the list of selected 
genes.  We cannot conclude that our list of selected genes is enriched for any pathways.  
We can instead consider each SNP as potentially perturbing pathways to which it 
belongs. 
The list of genes was found to overlap two gene networks by more than one gene: 
1. Cell-to-Cell Signaling and Interaction, Hematological System Development and 
Function, Immune Cell Trafficking (15 genes) 
2. Gene Expression, Connective Tissue Development and Function, Tissue 
Development (9 genes) 
Figures S19 and S20 show these networks. 
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Example Genes 
IDO2 (synonym: INDOL1) 
The non-synonymous SNP rs10109853 in gene IDO2 was found to be associated with 
microbial abundance of Firmicutes;Clostridia;Clostridiales;Veillonellaceae;Dialister and 
Firmicutes;Bacilli;Lactobacillales in the buccal mucosa body site.  This gene encodes an 
enzyme that contributes to tryptophan metabolism (Ball et al., 2007).  This enzyme 
participates in three host metabolic pathways: Tryptophan Degradation to 2-amino-3-
carbosymuconate Semialdehyde, NAD biosynthesis II (from tryptophan), and Tryptophan 
Degradation III (Eukaryotic).  Figures 4.3, 4.4, and 4.5 show associated microbial 
abundances and median abundances as functions of genotype. 
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Figure 4.3:  Transformed microbial abundance for V. Dialister as a function of genotype.  
This taxon is associated with gene IDO2. 
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Figure 4.4: Transformed microbial abundance for order Lactobacillales as a function of 
genotype.  This taxon is associated with gene IDO2. 
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Figure 4.5: Transformed median microbial abundances selected for SNP rs10109853 in 
gene IDO2 by genotype. 
 
ARSB 
The non-synonymous SNP rs1065757 in the gene ARSB was found to be associated 
with microbial taxa in the buccal mucosa body site: 
1. p__Cyanobacteria	  
2. p__Proteobacteria;c__Gammaproteobacteria,	  	  
3. p__Bacteroidetes;c__Flavobacteria;o__Flavobacteriales;f__Flavobacteriaceae;g_
_Capnocytophaga,	  	  
4. p__Tenericutes,	  
5. p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Streptococcaceae;Other	  
	  
This gene participates in the ‘Chondroitin Sulfate Degradation (metazoa)’ pathway.  
Figures 4.6, 4.7, 4.8, 4.9, and 4.10 show the associated microbial abundances and 
median abundances of four of the five microbial taxa found to associate with SNP 
rs1065757 in ARSB. 
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Figure 4.6: Transformed microbial abundance for Cyanobacteria as a function of 
genotype.  This taxon is associated with gene ARSB. 
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Figure 4.7: Transformed microbial abundance for Gammaproteobacteria as a function of 
genotype.  This taxon is associated with gene ARSB. 
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Figure 4.8: Transformed microbial abundance for Capnocytophaga as a function of 
genotype.  This taxon is associated with gene ARSB. 
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Figure 4.9: Transformed microbial abundance for Tenericutes as a function of genotype.  
This taxon is associated with gene ARSB. 
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Figure 4.10: Transformed median microbial abundances selected for SNP rs1065757 in 
gene ARSB by genotype. 
Pathway and Network Analysis of Permuted 16S Data 
As a check on the validity of our estimated false positive rate, we analyzed the top genes 
identified in the permuted 16S data for pathway and network enrichment.  We compiled 
a list of the top SNPs by ratio of median 𝑅! to width of the corresponding 95% 
confidence interval.  We retained the same number of SNPs from each body site as 
were retained in the real data.  Finally we removed SNPs with very high correlation to 
subject sex.  As with the real 16S data, most of the SNPs highly correlated to subject sex 
in the permuted data were in genes ALMS1 and FAM20A.  LUZP2 and C2orf16 were 
also found to be highly associated with subject sex.  The filtered gene list included 64 
unique genes.  This list is found in the spreadsheet hmp_16S_snps_genes.xlsx. 
Pathway analysis of the permuted 16S data reported five significant pathways but none 
included more than 4 identified genes.  The ‘Actin Cytoskeleton Signaling’ pathway was 
identified in the permuted 16S data and in the real 16S data.  This pathway includes 210 
genes. 
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Network analysis of the genes identified by the permuted 16S data reported two gene 
networks with more than 1 overlapping gene: 
1. Cellular Movement, Cellular Development, Cellular Growth and Proliferation 
2. Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry 
These networks were not identified by the network analysis of the actual 16S data. 	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5. HMP MGS KEGG Modules Results 
In addition to 16S sequencing, the Human Microbiome Project has released results of 
metagenomic shotgun sequencing on the samples from five body sites taken from a 
subset of subjects.  The metagenomic data has been processed using HUMANn 
(Abubucker et al., 2012) to produce tables of KEGG module and pathway abundance. 
We acquired KEGG module abundance tables from the HMP DACC.  For each body site 
250 KEGG module abundances are reported.  We did not preprocess the module 
abundances other than by applying the square-root-arcsin transformation.  We again 
included subject sex as part of the model. 
We applied our analysis pipeline to test for correlations between the table of transformed 
KEGG module abundances and the set of 32,696 exonic SNPs.  As before we filtered 
the data to remove SNPs with five or fewer samples of a single genotype, SNPs with 
fewer than 50 samples overall, and SNPs with minor allele frequency less than 0.2.  
Approximately 14,000 SNPs per body site remained after filtering.  Figure S21 shows the 
number of SNPs per body site that met the criteria for testing.  After testing we found 
300-400 SNPs per body site having 95% confidence interval of the median 𝑅! not 
overlapping 0.  We retained these SNPs for further analysis.  Figure S22 shows the 
counts of retained SNPs by body site. 
We estimated the false positive rate for each body site by running the LASSO regression 
program twice on each SNP after randomly permuting the SNP allele counts within the 
male and female groups. Those SNPs with a high correlation to sex were removed from 
the final list of SNPs correlated to KEGG module abundances.  Figure 5.1 shows the 
distribution of median 𝑅! values for both the real data and the average of the two 
distributions of the permuted data.  Supplemental figures S23-S26 show the same 
distributions for the remaining four body sites. 
Microbial taxa associated with well-correlated genes were again identified by 
randomized LASSO with stability score threshold 0.5. 
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Figure 5.1: Superimposed distributions of 𝑅! for actual and permuted data from the stool 
body site.  The figure on the left shows the distribution of SNPs with 𝑅! > 0.  The figure 
on the right shows the distribution of SNPs with 𝑅! > 0.1. It is clear in both figures that 
this body site is enriched for actual correlated SNPs. 
We again selected  𝑅! = 0.1 as a reasonable cutoff for considering a SNP to be well-
correlated with the HMP MGS KEGG module abundances.  The body sites most 
enriched for actual well-correlated SNPs were stool and tongue dorsum.  The 
supragingival plaque body site was only slightly enriched.  The anterior nares and buccal 
mucosa sites had no enrichment of well-correlated SNPs. 
Individual SNPs with high ratio 𝑟 of median 𝑅! to the width of the corresponding 95% 
confidence interval were identified as being well-correlated to the HMP MGS KEGG 
module abundances.  The supplemental spreadsheet 
‘hmp_mgs_kegg_modules_snps_genes.xlsx’ lists the identified SNPs and associated 
genes.  Figure S27 shows the final counts of identified SNPs per body site. 
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Pathway and Network Analysis 
We used QUIGEN’s Ingenuity Pathway Analysis (IPA, QUIGEN Redwood City, 
www.quiagen.com/ingenuity) to perform pathway and network analysis on the list of 
genes in hmp_mgs_kegg_modules_snps_genes.xlsx.  Figure S28 shows the results of 
pathway analysis. 
The list was found to be enriched for six pathways: 
1. Pregnenolone Biosynthesis (gene MICAL3) 
2. Histidine Degradation VI (gene MICAL3) 
3. Ubiquinol-10 Biosynthesis (Eukaryotic) (gene MICAL3) 
4. Mitochondrial L-carnitine Shuttle Pathway (gene CPT2) 
5. Coagulation System (gene PLG) 
6. Neuroprotective Role of THOP1 in Alzheimer's Disease (gene PLG) 
However, as with the results from 16S data these pathways include only one gene each 
from the list of selected genes.  As before we cannot conclude that our list of selected 
genes is enriched for these pathways. 
The list of genes was found to overlap seven gene networks: 
1. Cancer, Cell Cycle, Cell Morphology (gene PLEKHG2) 
2. Cellular Assembly and Organization, DNA Replication, Recombination, and 
Repair, Cell Cycle (gene RAI14) 
3. Cellular Movement, Cell-To-Cell Signaling and Interaction, Cellular Development 
(gene TJP3) 
4. Cellular Growth and Proliferation, Developmental Disorder, Hereditary Disorder – 
(gene CPT2) 
5. DNA Replication, Recombination, and Repair, Infectious Diseases, Hereditary 
Disorder (gene ASCC3) 
6. Cellular Development, Embryonic Development, Hair and Skin Development and 
Function (gene PSMB1) 
7. Cellular Movement, Cell-To-Cell Signaling and Interaction, Cellular Growth and 
Proliferation (gene PLG) 
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However, no network overlapped the list of selected genes by more than one gene. 
Example Gene 
PSMB1 (proteasome subunit, beta type, 1) 
The non-synonymous SNP rs12717 in gene PSMB1 was found to be associated with 
three KEGG modules from the stool body site: 
1. M00096:	  C5	  isoprenoid	  biosynthesis,	  non-­‐mevalonate	  pathway 
2. M00090:	  Phosphatidylcholine	  (PC)	  biosynthesis,	  choline	  =>	  PC 
3. M00321:	  Bicarbonate	  transport	  system 
This gene codes for a subunit of the proteasome, an enzyme complex that participates in 
degrading cellular proteins as well as MHC class 1 antigen presentation (Coux et al., 
1996).  Figures 5.2, 5.3, 5.4, and 5.5 show the KEGG module abundances associated 
with this SNP. 
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Figure 5.2: Transformed abundances for KEGG Module M00096: C5 isoprenoid 
biosynthesis, non-mevalonate pathway as a function of genotype.  This module is 
associated with gene PSMB1. 
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Figure 5.3: Transformed abundances for KEGG Module M00090: Phosphatidylcholine 
(PC) biosynthesis, choline => PC as a function of genotype.  This module is associated 
with gene PSMB1. 
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Figure 5.4: Transformed abundances for KEGG Module M00321: Bicarbonate transport 
system as a function of genotype.  This module is associated with gene PSMB1. 
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Figure 5.5: Transformed median microbial abundances selected for SNP rs12717 in 
gene PSMB1 by genotype.  Abundances of modules M00096 and M00090 are small 
relative to the abundances of module M00321. 
Pathway and Network Analysis of Permuted MGS KEGG Module Data 
As with the permuted 16S data, we analyzed the top genes identified in the permuted 
KEGG module abundance data for pathway and network enrichment as a check on the 
validity of our estimated false positive rate.  We compiled a list of the top SNPs by ratio 
of median 𝑅! to width of the corresponding 95% confidence interval from the permuted 
data.  We retained the same number of SNPs from each body site as were retained in 
the real KEGG module abundance data.  Finally we removed SNPs with very high 
correlation to subject sex (stability score > 0.8).  All of the SNPs highly correlated to 
subject sex in the permuted data were in genes ALMS1 and FAM20A.  The filtered gene 
list included 23 unique genes.  This list is found in the spreadsheet 
hmp_mgs_kegg_modules_snps_genes.xlsx. 
Pathway analysis of the permuted KEGG module abundance data reported five 
significant pathways but none included more than 2 identified genes.  None of these 
pathways was identified by the analysis of the real KEGG abundance data. 
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Network analysis of the genes identified by the permuted KEGG module abundance data 
reported one gene network with more than 1 overlapping gene: 
1. Gastrointestinal Disease, Hepatic System Disease, Liver Fibrosis 
This network was not identified by the network analysis of the actual KEGG module 
abundance data. 	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6. Discussion 
We have developed an analysis pipeline based on LASSO regression to screen for 
linear associations between human microbiome data, including abundance of taxonomic 
units as determined by 16S sequencing as well as KEGG module abundances derived 
from metagenomic shotgun sequencing, and host genetic variation in the form of SNPs. 
Using synthetic data we established the ability of our pipeline to detect associations we 
imagine might exist in real data.  We also observed limitations of our method with regard 
to noise in the data.  Our method is robust to noise in determining that correlation exists 
between host genetic variation and microbiome abundance.  Noise in the data has a 
more significant impact on feature selection. 
We applied our pipeline to two different types of microbiome data that share a common 
set of host genetic variation data, all of which came from the Human Microbiome Project.  
One set of microbiome data was taxon abundance determined by 16S sequencing, the 
second was KEGG module abundance determined by metagenomic shotgun 
sequencing.  While we do not find that the genes selected from the 16S data are 
enriched for any pathways, we find two genes each with a non-synonymous SNP that 
participate in pathways with potential interactions with human microbiota.  The genes 
identified by KEGG module abundances derived from metagenomic sequencing were 
not significantly enriched for any pathways either.  We do find a non-synonymous SNP in 
one gene that participates in a pathway that may be relevant to the microbiome. 
One of the genes identified by the 16S data at the buccal mucosa body site is IDO2, 
which participates in the pathway ‘Tryptophan Degradation to 2-amino-3-
carboxymuconate Semialdehyde’.  This pathway is present in eukaryotes and 
prokaryotes (“MetaCyc L-Tryptophan Degradation to 2-Amino-3-Carboxymuconate 
Semialdehyde.” 2015), and has been implicated as an important immune system 
pathway that contributes to suppressing inflammation (Opitz et al. 2007).  Suppressing 
the inflammatory response is a mechanism for maintaining commensal microbial 
communities (Chu and Mazmanian, 2013), and we observe a reduction in microbial 
abundances for the two associated taxa (family Veillonellaceae,	  genus	  Dialister	  and	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order	  Lactobacillales) with increasing alternate allele count.  The order Lactobacillales 
includes many organisms consumed by humans, while a species belonging to the 
Veillonellaceae	  Dialister	  	  genus,	  D.	  pneumonsintes,	  may	  be	  associated	  with	  periodontal	  
disease	  (Doan	  et	  al.,	  2000).	  	  Perhaps this host-genetic variation affects the hospitality of 
the oral cavity toward certain subcommunities. 
Another gene identified by the 16S data is ARSB, which participates in the pathway 
‘Chondroitin Sulfate Degradation (metazoa)’.  This pathway influences connective tissue 
permeability and bodily fluid viscosity.  Furthermore it may be promoted by bacteria in 
bacterial pathogenesis (Girish and Kemparaju, 2007; “Homo Sapiens Chondroitin Sulfate 
Degradation (metazoa).” 2015).  We observe one bacterial taxon that increases in 
abundance with increasing alternate allele count in SNP rs1065757:  genus 
Capnocytophaga.  This organism is a commensal member of oral communities but can 
act as a pathogen causing periodontal infections (Trude et al., 2005).  It is possible that 
variation in ARSB can give this organism a competitive advantage in the oral cavity, or it 
may give this organism the opportunity to colonize periodontal tissue. 
In the KEGG module abundance data derived from metagenomic shotgun sequencing 
we found association between a non-synonymous SNP in the gene PSMB1.  Of the 
three KEGG modules associated with this SNP, the strongest effect is seen in M00096:	  
C5	  isoprenoid	  biosynthesis,	  non-­‐mevalonate	  pathway.	  	  While	  isoprenoid	  biosynthesis	  is	  
a	  necessity	  for	  all	  cells,	  the	  non-­‐mevalonate	  pathway	  is	  used	  by	  bacteria	  and	  can	  initiate	  
an	  immune	  response	  (Heuston	  et	  al.,	  2012).	  	  Abundance	  of	  this	  module	  decreases	  with	  
increasing	  alternate	  allele	  count,	  which	  seems	  to	  indicate	  a	  reduction	  in	  pathogenic	  
activity	  related	  to	  this	  pathway. 
In looking at our results from real data we might at first be disappointed in the small 
number of SNPs we are able to say with confidence are correlated with microbiome 
data.  Considering our host genetic variation data is relatively small in terms of the 
number of samples per SNP we are optimistic that our results would be improved with 
larger data.  Furthermore the fact that no single gene was identified as well-correlated in 
both real and permuted data (except for those very highly correlated with subject sex) 
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gives us confidence that our estimate of the false positive rate is good.  Overall we 
believe we have constructed a reasonable method for finding linear relationships 
between the human microbiota abundances and host genetic variation. 
Despite our powerful genetic sequencing tools, the interpretation of genomic data is still 
in the early stages.  The information within sequenced genomes remains largely 
unavailable.  Methods such as ours are needed to automatically detect unknown 
relationships between host genetics and microbiome. 
Our method is quite specific in screening for linear associations.  The advantage of this 
tightly focused approach is computational efficiency and relatively simple 
implementation.  The disadvantage is that we will overlook relationships that do not 
follow the pattern our method recognizes.  A weakness that could be addressed is that 
we screen SNPs in isolation.  Our method could perhaps be extended to operate on 
groups of SNPs. 
At the other end of the complexity spectrum are deep-learning methods that make direct 
use of subtle genetic information such as splicing instructions found in introns (Xiong et 
al., 2015).  These methods have not been applied to microbiome data yet, but this is a 
growing area of research in machine learning and bioinformatics that may be best suited 
to uncovering unanticipated host-microbiome interactions. 
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Supplementary Figures 	  
	  
Figure S1: Final count of taxa per body site for HMP 16S data. 
tongue dorsum
throat
supragingival plaque
subgingival plaque
stool
saliva
right retroauricular crease
right antecubital fossa
palatine tonsils
left retroauricular crease
left antecubital fossa
hard palate
buccal mucosa
attached keratinized gingiva
anterior nares
0 100 200 300
taxon count
bo
dy
 si
te
Taxon Count per Body Site
HMP 16S
	  	  
52	  
	  
Figure S2: Count of tested SNPs per body site for HMP 16S data. 
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Figure S3: Count of SNPs with 95% confidence interval of median 𝑹𝟐 greater than 0. 
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Figure S4: Superimposed distributions of 𝑅! for actual and permuted data from the 
anterior nares body site.  The figure on the left shows the distribution of SNPs with 𝑅! > 0.  The figure on the right shows the distribution of SNPs with 𝑅! > 0.1. 
	  
Figure S5: Superimposed distributions of 𝑅! for actual and permuted data from the 
attached keratinized gingiva body site. 	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Figure S6: Superimposed distributions of 𝑅! for actual and permuted data from the 
buccal mucosa body site. 
	  
Figure S7: Superimposed distributions of 𝑅! for actual and permuted data from the hard 
palate body site. 
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Figure S8: Superimposed distributions of 𝑅! for actual and permuted data from the left 
antecubital fossa body site. 
	  
Figure S9: Superimposed distributions of 𝑅! for actual and permuted data from the left 
retroauricular crease body site. 	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Figure S10: Superimposed distributions of 𝑅! for actual and permuted data from the 
palatine tonsils body site. 
	  
Figure S11: Superimposed distributions of 𝑅! for actual and permuted data from the right 
antecubital fossa body site. 	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Figure S 12: Superimposed distributions of 𝑅! for actual and permuted data from the 
right retroauricular crease body site. 
	  
Figure S13: Superimposed distributions of 𝑅! for actual and permuted data from the 
saliva body site. 	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Figure S14: Superimposed distributions of 𝑅! for actual and permuted data from the 
subgingival plaque body site. 
	  
Figure S15: Superimposed distributions of 𝑅! for actual and permuted data from the 
supragingival plaque body site. 
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Figure S16: Superimposed distributions of 𝑅! for actual and permuted data from the 
throat body site. 
	  
Figure S17: Superimposed distributions of 𝑅! for actual and permuted data from the 
tongue dorsum body site. 
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Figure S18: Pathway analysis report from Ingenuity IPA for genes identified with HMP 
16S data. 
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Figure S19: Ingenuity IPA gene network 1 associated with HMP 16S gene list.  
Functions of the network are Cell-to-Cell Signaling and Interaction, Hematological 
System Development and Function, and Immune Cell Trafficking. 
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Figure S20: Ingenuity IPA gene network 2 associated with HMP 16S gene list.  
Functions of the network are Gene Expression, Connective Tissue Development and 
Function, Tissue Development. 
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Figure S21: Tested SNP counts per body site for HMP MGS HUMANn KEGG module 
abundances. 
tongue dorsum
supragingival plaque
stool
buccal mucosa
anterior nares
0 5000 10000
tested SNP count
bo
dy
 si
te
Tested SNP Count per Body Site
HMP MGS modules
	  	  
65	  
	  
Figure S22: Retained SNP counts per body site for HMP MGS HUMANn KEGG module 
abundances. 
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Figure S23: Superimposed distributions of 𝑅! for actual and permuted data from the 
anterior nares body site.  The figure on the left shows the distribution of SNPs with 𝑅! > 0.  The figure on the right shows the distribution of SNPs with 𝑅! > 0.1.   
	  
Figure S24: Superimposed distributions of 𝑅! for actual and permuted data from the 
buccal mucosa body site.  The figure on the left shows the distribution of SNPs with 𝑅! > 0.  The figure on the right shows the distribution of SNPs with 𝑅! > 0.1.   
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Figure S25: Superimposed distributions of 𝑅! for actual and permuted data from the 
supragingival plaque body site.  The figure on the left shows the distribution of SNPs 
with 𝑅! > 0.  The figure on the right shows the distribution of SNPs with 𝑅! > 0.1.   
	  
Figure S26: Superimposed distributions of 𝑅! for actual and permuted data from the 
tongue dorsum body site.  The figure on the left shows the distribution of SNPs with 𝑅! > 0.  The figure on the right shows the distribution of SNPs with 𝑅! > 0.1.   
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Figure S27: Final SNP counts per body site for HMP MGS HUMANn KEGG module 
abundances. 
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Figure S28: Ingenuity IPA pathway analysis results for genes with SNPs found to be 
correlated with HMP MGS HUMANn KEGG module abundances. 
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